Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Top Cited Papers
Open Access
- 19 December 2005
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 202 (12), 1691-1701
- https://doi.org/10.1084/jem.20050915
Abstract
Systemic anticancer chemotherapy is immunosuppressive and mostly induces nonimmunogenic tumor cell death. Here, we show that even in the absence of any adjuvantKeywords
This publication has 56 references indexed in Scilit:
- Apoptotic Cells Deliver Processed Antigen to Dendritic Cells for Cross-PresentationPLoS Biology, 2005
- Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificityCell Death & Differentiation, 2003
- Myocardial Expression of Baculoviral p35 Alleviates Doxorubicin-Induced Cardiomyopathy in RatsHuman Gene Therapy, 2003
- An atypical caspase-independent death pathway for an immunogenic cancer cell lineOncogene, 2002
- The CD8+ Dendritic Cell Subset Selectively Endocytoses Dying Cells in Culture and In VivoThe Journal of Experimental Medicine, 2002
- Death and anti-death: tumour resistance to apoptosisNature Reviews Cancer, 2002
- Tolerance to Islet Antigens and Prevention from Diabetes Induced by Limited Apoptosis of Pancreatic β CellsImmunity, 2002
- Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunityEuropean Journal of Immunology, 2001
- The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic CellsThe Journal of Experimental Medicine, 2000
- Specificity of the immune response leading to protection or enhancement by regressive and progressive variants of a rat colon carcinomaInternational Journal of Cancer, 1988